Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin augmentation of antidepressants for neurocognitive functioning in generalized anxiety disorder
2012-001779-35Phase 4Unknown
- Sponsor
- University of Southampton
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pregabalin in generalized anxiety disorder (GAD), sponsored by University of Southampton. Primary endpoints: Startle response at Week 6 and Antisaccade task performance at Week 6. Status: unknown.
02
Drugs
pregabalin
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2012-001779-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001779-35.